Showing results (281-290 of 527) with videos related to

Sort By:
Pageof 53
Interdisciplinary Cardiovascular and Thoracic Surgery|August 17, 2023
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancerAtsushi Kamigaichi, Takahiro Mimae, Norifumi Tsubokawa, et al.
Japanese Journal of Clinical Oncology|August 25, 2023
A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancerYoshinori Handa, Yasuhiro Tsutani, Takahiro Mimae, et al.
World Journal of Surgery|May 4, 2022
Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell CarcinomaRyosuke Hirohata, Yoichi Hamai, Jun Hihara, et al.
Clinical Lung Cancer|January 24, 2021
Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung CancerAtsushi Kamigaichi, Yasuhiro Tsutani, Takahiro Mimae, et al.
General Thoracic and Cardiovascular Surgery|June 10, 2025
Prognosis, imaging characteristics, and clinicopathological features of heavy smokers with clinical stage I lung adenocarcinoma: a multicenter studyIkki Takada, Yoshihisa Shimada, Takahiro Mimae, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 24, 2023
Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancerAtsushi Kamigaichi, Takahiro Mimae, Jun Amioka, et al.
World Journal of Surgery|January 26, 2017
Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal CancerYuta Ibuki, Yoichi Hamai, Jun Hihara, et al.
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 25, 2011
[Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma]Seiki Hasegawa, Fumihiro Tanaka, Morihito Okada, et al.
Respiration; International Review of Thoracic Diseases|August 18, 2015
The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CTTomoharu Yoshiya, Yoshihiro Miyata, Yuta Ibuki, et al.
Clinical Lung Cancer|February 28, 2020
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung CancerYoshinori Handa, Yasuhiro Tsutani, Noriyuki Shiroma, et al.
Pageof 53